Cancer Research AACR Legacy  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Y.
Right arrow Articles by Zhang, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.
Right arrow Articles by Zhang, L.
[Cancer Research 61, 2434-2438, March 15, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

RGD-Tachyplesin Inhibits Tumor Growth1

Yixin Chen, Xueming Xu, Shuigen Hong, Jinguo Chen, Ningfei Liu, Charles B. Underhill, Karen Creswell and Lurong Zhang2

Department of Oncology, Lombardi Cancer Center, Georgetown University Medical School, Washington, D.C. 20007 [X-M. X., J. C., N. F., C. B. U., K. C., L. Z.], and The Key Laboratory of China Education Ministry on Cell Biology and Tumor Cell Engineering, Xiamen University, Fujian 361005, People’s Republic of China [Y. C., S. H.]

Tachyplesin is an antimicrobial peptide present in leukocytes of the horseshoe crab (Tachypleus tridentatus). In this study, a synthetic tachyplesin conjugated to the integrin homing domain RGD was tested for antitumor activity. The in vitro results showed that RGD-tachyplesin inhibited the proliferation of both cultured tumor and endothelial cells and reduced the colony formation of TSU prostate cancer cells. Staining with fluorescent probes of FITC-annexin V, JC-1, YO-PRO-1, and FITC-dextran indicated that RGD-tachyplesin could induce apoptosis in both tumor and endothelial cells. Western blotting showed that treatment of cells with RGD-tachyplesin could activate caspase 9, caspase 8, and caspase 3 and increase the expression of the Fas ligand, Fas-associated death domain, caspase 7, and caspase 6, suggesting that apoptotic molecules related to both mitochondrial and Fas-dependent pathways are involved in the induction of apoptosis. The in vivo studies indicated that the RGD-tachyplesin could inhibit the growth of tumors on the chorioallantoic membranes of chicken embryos and in syngenic mice.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
H. L. Goel, J. Li, S. Kogan, and L. R Languino
Integrins in prostate cancer progression
Endocr. Relat. Cancer, September 1, 2008; 15(3): 657 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J.-K. Ko, K.-H. Choi, Z. Pan, P. Lin, N. Weisleder, C.-W. Kim, and J. Ma
The tail-anchoring domain of Bfl1 and HCCS1 targets mitochondrial membrane permeability to induce apoptosis
J. Cell Sci., August 15, 2007; 120(16): 2912 - 2923.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Papo, D. Seger, A. Makovitzki, V. Kalchenko, Z. Eshhar, H. Degani, and Y. Shai
Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic Peptide.
Cancer Res., May 15, 2006; 66(10): 5371 - 5378.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Capello, E. P. Krenning, B. F. Bernard, W. A.P. Breeman, J. L. Erion, and M. de Jong
Anticancer Activity of Targeted Proapoptotic Peptides
J. Nucl. Med., January 1, 2006; 47(1): 122 - 129.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Chen, X.-M. Xu, C. B. Underhill, S. Yang, L. Wang, Y. Chen, S. Hong, K. Creswell, and L. Zhang
Tachyplesin Activates the Classic Complement Pathway to Kill Tumor Cells
Cancer Res., June 1, 2005; 65(11): 4614 - 4622.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Papo, A. Braunstein, Z. Eshhar, and Y. Shai
Suppression of Human Prostate Tumor Growth in Mice by a Cytolytic D-, L-Amino Acid Peptide: Membrane Lysis, Increased Necrosis, and Inhibition of Prostate-Specific Antigen Secretion
Cancer Res., August 15, 2004; 64(16): 5779 - 5786.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. S. Aguzzi, C. Giampietri, F. De Marchis, F. Padula, R. Gaeta, G. Ragone, M. C. Capogrossi, and A. Facchiano
RGDS peptide induces caspase 8 and caspase 9 activation in human endothelial cells
Blood, June 1, 2004; 103(11): 4180 - 4187.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
W. Pan, X. Liu, F. Ge, J. Han, and T. Zheng
Perinerin, a Novel Antimicrobial Peptide Purified from the Clamworm Perinereis aibuhitensis Grube and Its Partial Characterization
J. Biochem., March 1, 2004; 135(3): 297 - 304.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Papo, M. Shahar, L. Eisenbach, and Y. Shai
A Novel Lytic Peptide Composed of DL-Amino Acids Selectively Kills Cancer Cells in Culture and in Mice
J. Biol. Chem., May 30, 2003; 278(23): 21018 - 21023.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Essler and E. Ruoslahti
Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature
PNAS, February 19, 2002; 99(4): 2252 - 2257.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.